Selected research
Industry Research
Glucoraphanin and Sulforaphane Industry Research Report 2026
Market perspective
The global Glucoraphanin and Sulforaphane market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucoraphanin and Sulforaphane is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucoraphanin and Sulforaphane is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucoraphanin and Sulforaphane is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucoraphanin and Sulforaphane include Brassica, CS Health, Ingood by Olga, ETChem, Pioneer Herb Industrial, Shanxi Yian and Anhui Bensentang Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucoraphanin and Sulforaphane market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucoraphanin and Sulforaphane Market by Company
Brassica
CS Health
Ingood by Olga
ETChem
Pioneer Herb Industrial
Shanxi Yian
Anhui Bensentang Biotechnology
Glucoraphanin and Sulforaphane Segment by Type
Glucoraphanin
Sulforaphane
Glucoraphanin and Sulforaphane Segment by Application
Health Products
Functional Foods
Pharmaceutical
Others
Glucoraphanin and Sulforaphane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucoraphanin and Sulforaphane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucoraphanin and Sulforaphane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucoraphanin and Sulforaphane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucoraphanin and Sulforaphane manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucoraphanin and Sulforaphane by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucoraphanin and Sulforaphane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucoraphanin
- Sulforaphane
Applications
- Health Products
- Functional Foods
- Pharmaceutical
- Others
Companies covered
- Brassica
- CS Health
- Ingood by Olga
- ETChem
- Pioneer Herb Industrial
- Shanxi Yian
- Anhui Bensentang Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucoraphanin and Sulforaphane Market Size (2021-2032)
- 2.2.2 Global Glucoraphanin and Sulforaphane Sales (2021-2032)
- 2.2.3 Global Glucoraphanin and Sulforaphane Market Average Price (2021-2032)
- 2.3 Glucoraphanin and Sulforaphane by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glucoraphanin
- 2.3.3 Sulforaphane
- 2.4 Glucoraphanin and Sulforaphane by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Health Products
- 2.4.3 Functional Foods
- 2.4.4 Pharmaceutical
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucoraphanin and Sulforaphane Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucoraphanin and Sulforaphane Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Glucoraphanin and Sulforaphane Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucoraphanin and Sulforaphane Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucoraphanin and Sulforaphane Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucoraphanin and Sulforaphane, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucoraphanin and Sulforaphane, Product Type & Application
- 3.8 Global Manufacturers of Glucoraphanin and Sulforaphane, Established Date
- 3.9 Global Glucoraphanin and Sulforaphane Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Brassica
- 4.1.1 Brassica Company Information
- 4.1.2 Brassica Business Overview
- 4.1.3 Brassica Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Brassica Glucoraphanin and Sulforaphane Product Portfolio
- 4.1.5 Brassica Recent Developments
- 4.2 CS Health
- 4.2.1 CS Health Company Information
- 4.2.2 CS Health Business Overview
- 4.2.3 CS Health Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CS Health Glucoraphanin and Sulforaphane Product Portfolio
- 4.2.5 CS Health Recent Developments
- 4.3 Ingood by Olga
- 4.3.1 Ingood by Olga Company Information
- 4.3.2 Ingood by Olga Business Overview
- 4.3.3 Ingood by Olga Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ingood by Olga Glucoraphanin and Sulforaphane Product Portfolio
- 4.3.5 Ingood by Olga Recent Developments
- 4.4 ETChem
- 4.4.1 ETChem Company Information
- 4.4.2 ETChem Business Overview
- 4.4.3 ETChem Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ETChem Glucoraphanin and Sulforaphane Product Portfolio
- 4.4.5 ETChem Recent Developments
- 4.5 Pioneer Herb Industrial
- 4.5.1 Pioneer Herb Industrial Company Information
- 4.5.2 Pioneer Herb Industrial Business Overview
- 4.5.3 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Product Portfolio
- 4.5.5 Pioneer Herb Industrial Recent Developments
- 4.6 Shanxi Yian
- 4.6.1 Shanxi Yian Company Information
- 4.6.2 Shanxi Yian Business Overview
- 4.6.3 Shanxi Yian Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanxi Yian Glucoraphanin and Sulforaphane Product Portfolio
- 4.6.5 Shanxi Yian Recent Developments
- 4.7 Anhui Bensentang Biotechnology
- 4.7.1 Anhui Bensentang Biotechnology Company Information
- 4.7.2 Anhui Bensentang Biotechnology Business Overview
- 4.7.3 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Product Portfolio
- 4.7.5 Anhui Bensentang Biotechnology Recent Developments
5 Global Glucoraphanin and Sulforaphane Market Scenario by Region
- 5.1 Global Glucoraphanin and Sulforaphane Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucoraphanin and Sulforaphane Sales by Region: 2021-2032
- 5.2.1 Global Glucoraphanin and Sulforaphane Sales by Region: 2021-2026
- 5.2.2 Global Glucoraphanin and Sulforaphane Sales by Region: 2027-2032
- 5.3 Global Glucoraphanin and Sulforaphane Revenue by Region: 2021-2032
- 5.3.1 Global Glucoraphanin and Sulforaphane Revenue by Region: 2021-2026
- 5.3.2 Global Glucoraphanin and Sulforaphane Revenue by Region: 2027-2032
- 5.4 North America Glucoraphanin and Sulforaphane Market Facts & Figures by Country
- 5.4.1 North America Glucoraphanin and Sulforaphane Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucoraphanin and Sulforaphane Sales by Country (2021-2032)
- 5.4.3 North America Glucoraphanin and Sulforaphane Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucoraphanin and Sulforaphane Market Facts & Figures by Country
- 5.5.1 Europe Glucoraphanin and Sulforaphane Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucoraphanin and Sulforaphane Sales by Country (2021-2032)
- 5.5.3 Europe Glucoraphanin and Sulforaphane Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucoraphanin and Sulforaphane Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucoraphanin and Sulforaphane Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucoraphanin and Sulforaphane Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucoraphanin and Sulforaphane Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucoraphanin and Sulforaphane Market Facts & Figures by Country
- 5.7.1 South America Glucoraphanin and Sulforaphane Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucoraphanin and Sulforaphane Sales by Country (2021-2032)
- 5.7.3 South America Glucoraphanin and Sulforaphane Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucoraphanin and Sulforaphane Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucoraphanin and Sulforaphane Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucoraphanin and Sulforaphane Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucoraphanin and Sulforaphane Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucoraphanin and Sulforaphane Sales by Type (2021-2032)
- 6.1.1 Global Glucoraphanin and Sulforaphane Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Glucoraphanin and Sulforaphane Sales Market Share by Type (2021-2032)
- 6.2 Global Glucoraphanin and Sulforaphane Revenue by Type (2021-2032)
- 6.2.1 Global Glucoraphanin and Sulforaphane Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucoraphanin and Sulforaphane Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucoraphanin and Sulforaphane Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucoraphanin and Sulforaphane Sales by Application (2021-2032)
- 7.1.1 Global Glucoraphanin and Sulforaphane Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Glucoraphanin and Sulforaphane Sales Market Share by Application (2021-2032)
- 7.2 Global Glucoraphanin and Sulforaphane Revenue by Application (2021-2032)
- 7.2.1 Global Glucoraphanin and Sulforaphane Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucoraphanin and Sulforaphane Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucoraphanin and Sulforaphane Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucoraphanin and Sulforaphane Value Chain Analysis
- 8.1.1 Glucoraphanin and Sulforaphane Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucoraphanin and Sulforaphane Production Mode & Process
- 8.2 Glucoraphanin and Sulforaphane Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucoraphanin and Sulforaphane Distributors
- 8.2.3 Glucoraphanin and Sulforaphane Customers
9 Global Glucoraphanin and Sulforaphane Analyzing Market Dynamics
- 9.1 Glucoraphanin and Sulforaphane Industry Trends
- 9.2 Glucoraphanin and Sulforaphane Industry Drivers
- 9.3 Glucoraphanin and Sulforaphane Industry Opportunities and Challenges
- 9.4 Glucoraphanin and Sulforaphane Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst